Angiogenesis Inhibitors: all 4,430 studies that test it
Page 32 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Squalamine for the Treatment in Proliferative Diabetic RetinopathyCompletedNCT01769183Phase 2
- Dexamethasone-implant for the Treatment of RVOCompletedNCT01767545Phase 4
- A Phase IB Study Of The BTKi CC-292 Combined With Lenalidomide In Adults Patients With Relapsed/Refractory B-Cell LymphomaCompletedNCT01766583Phase 1
- Paclitaxel-bevacizumab in Advanced Lung CancerCompletedNCT01763671Phase 3
- Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal CancerStatus unknownNCT01763450Phase 2
- Chemoradiotherapy for Patients With Oligometastatic Colorectal CancerTerminatedNCT01759238Phase 2
- ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic TumorsCompletedNCT01756989Phase 2
- Ipilimumab and Lenalidomide in Advanced CancerCompletedNCT01750983Phase 1
- Lenalidomide After Allo TransplantTerminatedNCT01750762Phase 1
- SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM PatientsCompletedNCT01749969Phase 1
- Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryCompletedNCT01749384Phase 1
- A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in EyesTerminatedNCT01746875Not applicable
- Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyCompletedNCT01746563Phase 1/2
- Bevacizumab/Doxorubicin/Radiation for SarcomaActive, not recruitingNCT01746238Phase 1
- Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)CompletedNCT01745640Phase 2
- Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid MalignanciesTerminatedNCT01744912Phase 1
- Subconjunctival Bevacizumab and Recurrent PterygiumCompletedNCT01744756Phase 2/3
- An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)TerminatedNCT01742793Phase 1
- A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially UnresectableCompletedNCT01739218Phase 2
- Bendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCLCompletedNCT01737177Phase 2
- Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision ManagementCompletedNCT01736449Phase 4
- Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian CancerCompletedNCT01735071Phase 2
- Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLCCompletedNCT01733589Phase 1/2
- Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic LymphomaCompletedNCT01732861Phase 1
- A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid TumorsStatus unknownNCT01731925Phase 2
- Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell LymphomaTerminatedNCT01729104Phase 1
- First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDDTerminatedNCT01728259Phase 1
- Impact of Intravitreal Aflibercept Injections on Capillary Non-PerfusionCompletedNCT01724554Phase 1/2
- Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT01724385Phase 4
- A Biomarker Study in Patients With HER2-negative Metastatic Breast Cancer Treated With Bevacizumab and PaclitaxelCompletedNCT01722968Phase 2
- Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial DetachmentCompletedNCT01722656Phase 4
- Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular LymphomaCompletedNCT01722305Phase 1
- Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.CompletedNCT01718379Phase 2
- A Study of Sunitinib in Patients With Advanced CholangiocarcinomaCompletedNCT01718327Phase 2
- Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent NeuroblastomaActive, not recruitingNCT01711554Phase 1
- A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male SubjectsCompletedNCT01707407Phase 1
- Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With BevacizumabStatus unknownNCT01706120Phase 4
- Bevacizumab vs Dacarbazine in Metastatic MelanomaTerminatedNCT01705392Phase 2
- Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.CompletedNCT01705184Phase 2
- Fludarabine/Rituximab Combined With Escalating Doses of Lenalidomide in Untreated CLLCompletedNCT01703364Phase 1/2
- Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide MaintenanceCompletedNCT01702831Phase 2
- Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung CancerCompletedNCT01700400Phase 1
- Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid MalignanciesCompletedNCT01688960Phase 1
- Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)CompletedNCT01687439Phase 2
- Bevacizumab for Primary Pterygium TreatmentCompletedNCT01686529Phase 1
- Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed MyelomaStatus unknownNCT01686386Phase 1/2
- Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney CancerActive, not recruitingNCT01684397Phase 1/2
- Lenalidomide Plus Chemotherapy for AMLCompletedNCT01681537Phase 1
- Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal CancerStatus unknownNCT01679327Phase 2
- Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)CompletedNCT01678963Phase 2
- Intra-arterial Hepatic Bevacizumab and Systemic ChemotherapyCompletedNCT01677884Phase 2
- Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)Status unknownNCT01676506Not applicable
- TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IVWithdrawnNCT01674738Phase 2
- Lenalidomide After Failure of Hypomethylating Agents in Myelodysplastic SyndromeStatus unknownNCT01673308Phase 2
- On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)Status unknownNCT01670162Phase 4
- Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisStatus unknownNCT01669447Phase 4
- Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung CancerCompletedNCT01666977Phase 1/2
- An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese SubjectsCompletedNCT01666691Phase 2
- Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsCompletedNCT01661400Phase 1
- Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) PatientsCompletedNCT01658033Phase 2
- Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term ResultsStatus unknownNCT01657669Phase 4
- A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular LymphomaCompletedNCT01650701Phase 3
- Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib MaintenanceWithdrawnNCT01647165Phase 2
- Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver MetastasesWithdrawnNCT01646554Phase 2/3
- Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular LymphomaCompletedNCT01644799Phase 1
- Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MFCompletedNCT01644110Phase 1/2
- "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"Status unknownNCT01641406Phase 2
- THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt FailureStatus unknownNCT01640639Phase 4
- Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)CompletedNCT01640444Phase 2
- Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral CellsCompletedNCT01640405Phase 3
- POEMS Syndrome Treatment With LenalidomideCompletedNCT01639898Phase 2
- Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)CompletedNCT01638858Not applicable
- Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent ImplantationStatus unknownNCT01638078Phase 4
- Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.CompletedNCT01636908Not applicable
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)Status unknownNCT01635803Phase 2/3
- Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)Status unknownNCT01635790Phase 2/3
- A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01633970Phase 1
- Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver MetsCompletedNCT01632722Phase 2
- Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid LeukemiaCompletedNCT01629082Phase 1
- Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular DegenerationCompletedNCT01628354Phase 4
- CRLX101 Plus Bevacizumab in Advanced RCCCompletedNCT01625936Phase 1
- Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung CancerStatus unknownNCT01623102Phase 2
- Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple MyelomaTerminatedNCT01617213Phase 2
- Phase I Study of Lenalidomide in Patients With Acute LeukemiaTerminatedNCT01615042Phase 1
- Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01612286Phase 2
- Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + LenalidomideTerminatedNCT01604031Phase 1
- Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple MyelomaCompletedNCT01593410Phase 2
- Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple MyelomaCompletedNCT01583283Phase 1
- Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell LymphomaCompletedNCT01582776Phase 1/2
- Intravitreal Aflibercept Injection for Radiation RetinopathyCompletedNCT01579760Phase 1
- Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard InductionCompletedNCT01578954Phase 1
- Intravitreal Aflibercept Injection (IAI) for Presumed Ocular Histoplasmosis SyndromeCompletedNCT01578720Phase 1
- Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular EdemaCompletedNCT01572350Phase 3
- Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refractory or Relapsed and Refractory Multiple MyelomaCompletedNCT01568294Phase 1
- The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With EndostarStatus unknownNCT01564329Phase 2
- The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular OedemaCompletedNCT01564108Phase 2
- Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple MyelomaActive, not recruitingNCT01562405Phase 1
- A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic LeukemiaCompletedNCT01558167Phase 1/2
- A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line TherapyCompletedNCT01556776Phase 3
- The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).Status unknownNCT01556477Phase 2